Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 624

1.

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.

Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L.

Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Review.

2.

The effects of cannabinoids on the endocrine system.

Borowska M, Czarnywojtek A, Sawicka-Gutaj N, Woliński K, Płazińska MT, Mikołajczak P, Ruchała M.

Endokrynol Pol. 2018;69(6):705-719. doi: 10.5603/EP.a2018.0072. Review.

3.

Health-related quality of life across cancer cachexia stages.

Kasvis P, Vigano M, Vigano A.

Ann Palliat Med. 2019 Jan;8(1):33-42. doi: 10.21037/apm.2018.08.04. Epub 2018 Sep 5. Review.

4.

What do Cochrane systematic reviews say about the use of cannabinoids in clinical practice?

Latorraca COC, Pacheco RL, Martimbianco ALC, Pachito DV, Riera R.

Sao Paulo Med J. 2018 Sep-Oct;136(5):472-478. doi: 10.1590/1516-3180.2018.0313210818. Epub 2018 Oct 22.

5.

Cannabinoids for the treatment of cannabis abuse disorder.

Rodríguez A, Zavala C.

Medwave. 2018 Oct 11;18(6):e7287. doi: 10.5867/medwave.2018.06.7286. Review. Spanish, English.

PMID:
30339139
6.

Cannabis and epilepsy.

Thomas RH, Cunningham MO.

Pract Neurol. 2018 Dec;18(6):465-471. doi: 10.1136/practneurol-2018-002058. Epub 2018 Oct 18. Review.

PMID:
30337476
7.

A multifactorial critical appraisal of substances found in drug facilitated sexual assault cases.

Grela A, Gautam L, Cole MD.

Forensic Sci Int. 2018 Nov;292:50-60. doi: 10.1016/j.forsciint.2018.08.034. Epub 2018 Sep 3. Review.

PMID:
30292936
8.

Cannabinoids in depressive disorders.

Poleszak E, Wośko S, Sławińska K, Szopa A, Wróbel A, Serefko A.

Life Sci. 2018 Nov 15;213:18-24. doi: 10.1016/j.lfs.2018.09.058. Epub 2018 Oct 3. Review.

PMID:
30290188
9.

Occupational health and safety in cannabis production: an Australian perspective.

Davidson M, Reed S, Oosthuizen J, O'Donnell G, Gaur P, Cross M, Dennis G.

Int J Occup Environ Health. 2018 Jul - Oct;24(3-4):75-85. doi: 10.1080/10773525.2018.1517234. Epub 2018 Oct 3. Review.

PMID:
30281413
10.

A review on the abuse of three NPS (synthetic cannabinoids, kratom, poppers) among youths in Asia.

Bae K, Kwon NJ, Han E.

Forensic Sci Int. 2018 Nov;292:45-49. doi: 10.1016/j.forsciint.2018.09.008. Epub 2018 Sep 19. Review.

PMID:
30273913
11.

Cannabinoid Delivery Systems for Pain and Inflammation Treatment.

Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F.

Molecules. 2018 Sep 27;23(10). pii: E2478. doi: 10.3390/molecules23102478. Review.

12.

Epigenetic Effects of Drugs of Abuse.

Heinbockel T, Csoka AB.

Int J Environ Res Public Health. 2018 Sep 25;15(10). pii: E2098. doi: 10.3390/ijerph15102098. Review.

13.

A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis.

Arroyo González R.

Expert Rev Neurother. 2018 Oct;18(10):785-791. doi: 10.1080/14737175.2018.1510772. Epub 2018 Sep 20. Review.

PMID:
30235965
14.

Synthetic cannabinoids in biological specimens: a review of current analytical methods and sample preparation techniques.

Rosado T, Gonçalves J, Luís Â, Malaca S, Soares S, Vieira DN, Barroso M, Gallardo E.

Bioanalysis. 2018 Oct 1;10(19):1609-1623. doi: 10.4155/bio-2018-0150. Epub 2018 Sep 18. Review.

PMID:
30226077
15.

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history.

Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, Mastinu A.

J Ethnopharmacol. 2018 Dec 5;227:300-315. doi: 10.1016/j.jep.2018.09.004. Epub 2018 Sep 8. Review.

PMID:
30205181
16.

Role of Cannabinoids in Obesity.

Rossi F, Punzo F, Umano GR, Argenziano M, Miraglia Del Giudice E.

Int J Mol Sci. 2018 Sep 10;19(9). pii: E2690. doi: 10.3390/ijms19092690. Review.

17.

The acute effects of cannabis on human executive function.

Oomen PP, van Hell HH, Bossong MG.

Behav Pharmacol. 2018 Oct;29(7):605-616. doi: 10.1097/FBP.0000000000000426. Review.

PMID:
30199388
18.

Cannabis for the Treatment of Epilepsy: an Update.

Gaston TE, Szaflarski JP.

Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Review.

PMID:
30194563
19.

Social Factors and Animal Models of Cannabis Use.

Hood L.

Int Rev Neurobiol. 2018;140:171-200. doi: 10.1016/bs.irn.2018.07.006. Epub 2018 Aug 17. Review.

PMID:
30193704
20.

Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science.

Herrmann ES, Jarvis BP, Sparks AC, Cohn AM, Koszowski B, Rosenberry ZR, Coleman-Cowger VH, Pickworth WB, Peters EN.

Int Rev Psychiatry. 2018 Jun;30(3):238-250. doi: 10.1080/09540261.2018.1465400. Review.

Supplemental Content

Loading ...
Support Center